Rainess, R., Campbell, P., Santamala, J., Kubin, C. J., & Mehta, M. (2022). Outcomes Associated with De-escalation of Antibiotics to Target Positive Cultures when Treating Febrile Neutropenia. Journal of Pharmacy Practice, 37(2), 301–306. https://doi.org/10.1177/08971900221132120

Kubota, Y., & Viny, A. D. (2024). Germline predisposition for clonal hematopoiesis. Seminars in Hematology, 61(1), 61–67. https://doi.org/10.1053/j.seminhematol.2024.01.007

Levy, B., Kanagal‐Shamanna, R., Sahajpal, N. S., Neveling, K., Rack, K., Dewaele, B., Olde Weghuis, D., Stevens‐Kroef, M., Puiggros, A., Mallo, M., Clifford, B., Mantere, T., Hoischen, A., Espinet, B., Kolhe, R., Solé, F., Raca, G., & Smith, A. C. (2024). A framework for the clinical implementation of optical genome mapping in hematologic malignancies. American Journal of Hematology, 99(4), 642–661. Portico. https://doi.org/10.1002/ajh.27175

Nabeel, H., & Alobeid, B. (2023). Utility of Flow Cytometry Analysis in the Detection of Nonhematologic Neoplasms. Clinics in Laboratory Medicine, 43(3), 455–465. https://doi.org/10.1016/j.cll.2023.05.001

Lee, T. D., Aisner, D. L., David, M. P., Eno, C. C., Gagan, J., Gocke, C. D., Guseva, N. V., Haley, L., Jajosky, A. N., Jones, D., Mansukhani, M. M., Mroz, P., Murray, S. S., Newsom, K. J., Paulson, V., Roy, S., Rushton, C., Segal, J. P., Senaratne, T. N., … Kim, A. S. (2023). Current clinical practices and challenges in molecular testing: a GOAL Consortium Hematopathology Working Group report. Blood Advances, 7(16), 4599–4607. https://doi.org/10.1182/bloodadvances.2023010149

Ali, A. M., BenMohamed, F., Decina, A., Mukherjee, S., Levi, S., Garrido Castillo, L. N., Bréchot, D., Jurcic, J., Raza, A., & Paterlini Bréchot, P. (2023). Circulating cancer giant cells with unique characteristics frequently found in patients with myelodysplastic syndromes (MDS). Medical Oncology, 40(7). https://doi.org/10.1007/s12032-023-02064-z

Bolaños-Meade, J., Hamadani, M., Wu, J., Al Malki, M. M., Martens, M. J., Runaas, L., Elmariah, H., Rezvani, A. R., Gooptu, M., Larkin, K. T., Shaffer, B. C., El Jurdi, N., Loren, A. W., Solh, M., Hall, A. C., Alousi, A. M., Jamy, O. H., Perales, M.-A., Yao, J. M., … Holtan, S. G. (2023). Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis. New England Journal of Medicine, 388(25), 2338–2348. https://doi.org/10.1056/nejmoa2215943

Labella, R., Vujačić, M., & Trivanović, D. (2023). Bone Marrow Adipose Tissue: Regulation of Osteoblastic Niche, Hematopoiesis and Hematological Malignancies. Stem Cell Reviews and Reports, 19(5), 1135–1151. https://doi.org/10.1007/s12015-023-10531-3

Totiger, T. M., Chaudhry, S., Musi, E., Afaghani, J., Montoya, S., Owusu‐Ansah, F., Lee, S., Schwartz, G., Klimek, V., & Taylor, J. (2023). Protein biomarkers for response to XPO1 inhibition in haematologic malignancies. Journal of Cellular and Molecular Medicine, 27(4), 587–590. Portico. https://doi.org/10.1111/jcmm.17667

Leuva, H., Zhou, M., Brau, N., Brown, S. T., Mundi, P., Rosenberg, T.-C. M., Luhrs, C., Bates, S. E., Park, Y.-H. A., & Fojo, T. (2022). Influence of Cancer on COVID-19 Incidence, Outcomes, and Vaccine Effectiveness: A Prospective Cohort Study of U.S. Veterans. Seminars in Oncology, 49(5), 363–370. https://doi.org/10.1053/j.seminoncol.2022.07.005

Alaggio, R., Amador, C., Anagnostopoulos, I., Attygalle, A. D., Araujo, I. B. de O., Berti, E., Bhagat, G., Borges, A. M., Boyer, D., Calaminici, M., Chadburn, A., Chan, J. K. C., Cheuk, W., Chng, W.-J., Choi, J. K., Chuang, S.-S., Coupland, S. E., Czader, M., Dave, S. S., … Xiao, W. (2022). The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia, 36(7), 1720–1748. https://doi.org/10.1038/s41375-022-01620-2

Akkari, Y. M. N., Baughn, L. B., Dubuc, A. M., Smith, A. C., Mallo, M., Dal Cin, P., Diez Campelo, M., Gallego, M. S., Granada Font, I., Haase, D. T., Schlegelberger, B., Slavutsky, I., Mecucci, C., Levine, R. L., Hasserjian, R. P., Solé, F., Levy, B., & Xu, X. (2022). Guiding the global evolution of cytogenetic testing for hematologic malignancies. Blood, 139(15), 2273–2284. https://doi.org/10.1182/blood.2021014309

Gregory, G. P., Kumar, S., Wang, D., Mahadevan, D., Walker, P., Wagner-Johnston, N., Escobar, C., Bannerji, R., Bhutani, D., Chang, J., Hernandez-Ilizaliturri, F. J., Klein, A., Pagel, J. M., Rybka, W., Yee, A. J., Mohrbacher, A., Huang, M., Farooqui, M., Marinello, P., & Quach, H. (2022). Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study. Blood Advances, 6(4), 1232–1242. https://doi.org/10.1182/bloodadvances.2021005872